GLP-1 (glucagon-like peptide-1) medications are powerful tools in the fight against chronic weight management and metabolic challenges
Their logic is that we have survived Atkins, Keto, and Paleo, and that ultimately, biology beats ideology
Many patients begin to notice subtle changes during week 3, including a modest reduction in appetite and a feeling of fullness after smaller meals
These include: Pre-existing constipation or slow transit constipation Inadequate dietary fibre intake Insufficient fluid consumption Reduced physical activity levels Concurrent medications with constipating effects (such as opioids, certain antidepressants, or iron supplements) Older age , where baseline colonic motility may already be reduced The severity of constipation often correlates with the dose of medication and may be more pronounced during dose escalation phases
Our state-of-the-art facilities encompass more than 10 modern production lines within 100,000-level purification workshops, ensuring pharmaceutical-grade manufacturing environments meeting global standards